In vitro, HTLV-1-infected glioma stem cells (GSCs) alter glutamate metabolism and increase production of granulocyte-macrophage colony-stimulating factor (GM-CSF), Tumor Necrosis Factor-alpha (TNF-α), IL-1α, and IL-6 [14,16]. The gene discussed is CSF2; the disease is central nervous system cancer.